A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder
Clinical trial NCT03664232 · COMPLETED
Trial details
- NCT number
- NCT03664232
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2022-10-17
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.